Barry G.W. Arnason

University of Chicago — United States

Medicine · Health Sciences

50h-index8.4kcitations183works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(49), Peripheral Neuropathies and Disorders(25), Monoclonal and Polyclonal Antibodies Research(22), Immunotherapy and Immune Responses(18), T-cell and B-cell Immunology(15)

Publications183 total

Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection
EBioMedicine·2019· 61 citedOpen Access
Effect of <i>HLA-DRB1</i> alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials
Multiple Sclerosis Journal·2018· 9 citedOpen Access
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial
Journal of Neurology·2016· 50 citedOpen Access
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b
JAMA Neurology·2015· 165 cited
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b
Journal of Neurology·2015· 5 citedOpen Access
Studies of Immune Regulation in MS using Monoclonal Antibodies against T Cell Subsets
2015· 1 cited
Efficacy and safety of interferon beta-1b sc in older RRMS patients—a posthoc analysis of the BEYOND study
Journal of Neurology·2013· 9 cited
Variability in detection and quantification of interferon β-1b–induced neutralizing antibodies
Journal of Neuroinflammation·2012· 11 citedOpen Access
Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial
Multiple Sclerosis Journal·2011· 35 cited
Treatment of Infantile Spasms
Journal of Child Neurology·2011· 67 citedOpen Access
Rapid Immune Responses to a Botulinum Neurotoxin Hc Subunit Vaccine through <i>In Vivo</i> Targeting to Antigen-Presenting Cells
Infection and Immunity·2011· 17 citedOpen Access
Olig1 is expressed in human oligodendrocytes during maturation and regeneration
Glia·2011· 47 cited
Foreword
Neuroimmune biology·2010
The Hypothalamus is the Central Organ of Immunoregulation
Neuroimmune biology·2010· 3 cited
Preface
Neuroimmune biology·2010
Multiple Sclerosis and Depression: A Neuroimmunological Perspective
Neuroimmune biology·2010· 3 cited
Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon β-1b
Multiple Sclerosis Journal·2009· 27 cited
250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
The Lancet Neurology·2009· 402 citedOpen Access
Optimizing Outcomes in Multiple Sclerosis – A Consensus Initiative
Multiple Sclerosis Journal·2009
Terbutaline in myasthenia gravis: A pilot study
Journal of the Neurological Sciences·2008· 27 cited
page 1 of 10Next →

Frequent Co-authors

Anthony T. Reder(7), Byron H. Waksman(5), Branislav D. Janković(4), Joël Oger(4), David P. Richman(4), Mark A. Jensen(4), Jack P. Antel(3), Raymond P. Roos(3), James R. Lehrich(3), Michael Young(3), Joseph W. Karaszewski(3), Arthur K. Asbury(2), Paul O’Connor(2), Massimo Filippi(2), Gıancarlo Comı(2), Stuart D. Cook(2), Douglas S. Goodin(2), Hans-Peter Hartung(2), Douglas Jeffery(2), Ludwig Kappos(2)